Back to HRT Financial LP HRT Financial LP

ZYME

Showing 8 of 10 quarters

Position history for HRT Financial LPHRT Financial LP's holdings in Zymeworks Inc.

No. HRT Financial exited its ZYME (Zymeworks) position in Q2 2026. Its Q1 2026 13F listed 237,889 shares worth $6M. HRT Financial first reported ZYME in Q1 2023 and held it in 8 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$612,000

Total Shares Change

-48,808

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$26.14
0
2026-Q1
Increased
237,889
+96.5%
$6M0.0%$24.45
43
2025-Q4
Increased
121,064
+76.8%
$3.2M0.0%$26.54
40
2025-Q3
Increased
68,461
+109.0%
$1.2M0.0%$17.23
41
2025-Q2
Decreased
32,758
-49.9%
$411,0000.0%$12.47
0
2025-Q1
Decreased
65,380
-31.9%
$778,0000.0%$12.37
0
2024-Q4
Increased
95,974
+96.6%
$1.4M0.0%$14.51
41
2024-Q3
New
48,808
-
$612,0000.0%$12.42
34

Other major holders of ZYME: BlackRock, Inc., Morgan Stanley

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used